These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20830258)

  • 21. An inappropriate pacing threshold increase after repeated electrical storm in a patient with implantable cardioverter defibrillator.
    Zhu Y; Gu X; Xu C
    BMC Cardiovasc Disord; 2017 Oct; 17(1):265. PubMed ID: 29037154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective Evaluation of Implantable Cardioverter-Defibrillator Lead Function During and After Left Ventricular Assist Device Implantation.
    Hu YL; Kasirajan V; Tang DG; Shah KB; Koneru JN; Grizzard JD; Ellenbogen KA; Kron J
    JACC Clin Electrophysiol; 2016 Jun; 2(3):343-354. PubMed ID: 29766894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, management, and prevention of right ventricular perforation by pacemaker and implantable cardioverter defibrillator leads.
    Migliore F; Zorzi A; Bertaglia E; Leoni L; Siciliano M; De Lazzari M; Ignatiuk B; Veronese M; Verlato R; Tarantini G; Iliceto S; Corrado D
    Pacing Clin Electrophysiol; 2014 Dec; 37(12):1602-9. PubMed ID: 25131984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.
    Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P
    Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implantable cardiac defibrillator leads dysfunction after LVAD implantation.
    Galand V; Leclercq C; Bourenane H; Boulé S; Vincentelli A; Maury P; Mondoly P; Picard F; Welté N; Kindo M; Cardi T; Pasquié JL; Gaudard P; Gourraud JB; Probst V; Defaye P; Boignard A; Para M; Algalarrondo V; Pelcé E; Gariboldi V; Pozzi M; Obadia JF; Anselme F; Litzler PY; Blanchart K; Babatasi G; Garnier F; Bielefeld M; Hamon D; Lellouche N; Bourguignon T; Pierre B; Eschalier R; D'Ostrevy N; Varlet E; Marijon E; Blangy H; Sadoul N; Flécher E; Martins RP
    Pacing Clin Electrophysiol; 2020 Nov; 43(11):1309-1317. PubMed ID: 32627211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implantable cardioverter defibrillator therapy in young individuals: comparison of conventional and subcostal approaches-a single-centre experience.
    Irfan G; Czapla J; Saitoh Y; Ciconte G; Mugnai G; Conte G; Hunuk B; Velagic V; Stroker E; Chierchia GB; Nijs J; La Meir M; Wellens F; Brugada P; De Asmundis C
    Europace; 2017 Jan; 19(1):81-87. PubMed ID: 26893495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inappropriate subcutaneous implantable cardioverter defibrillator shock due to incomplete sealing of the seal plug: a case report.
    Ajimi T; Nozoe M; Suematsu N; Kubota T
    Eur Heart J Case Rep; 2022 Sep; 6(9):ytac366. PubMed ID: 36196146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Riata lead failure manifests as electrical storm with lead parameters showing unique postural variations: a case report.
    Uppal A; Kathuria S; Shah B; Trehan V
    Eur Heart J Case Rep; 2021 Dec; 5(12):ytab491. PubMed ID: 34909577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
    JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subclinical atrial fibrillation detection with a floating atrial sensing dipole in single lead implantable cardioverter-defibrillator systems: Results of the SENSE trial.
    Thomas G; Choi DY; Doppalapudi H; Richards M; Iwai S; Daoud EG; Houmsse M; Kanagasundram AN; Mainigi SK; Lubitz SA; Cheung JW
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1994-2001. PubMed ID: 31328298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution in transvenous extraction of pacemaker and implantable cardioverter defibrillator leads using a mechanical dilator sheath.
    Oto A; Aytemir K; Canpolat U; Yorgun H; Şahiner L; Kaya EB; Kabakçi G; Tokgözoğlu L
    Pacing Clin Electrophysiol; 2012 Jul; 35(7):834-40. PubMed ID: 22486778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lead extraction: a new effective tool to overcome fibrous binding sites.
    Dello Russo A; Biddau R; Pelargonio G; Casella M; Frontera A; Camporeale A; Bisceglia C; Forleo GB; Tondo C; Zecchi P; Bellocci F
    J Interv Card Electrophysiol; 2009 Mar; 24(2):147-50. PubMed ID: 18987963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and predictors of implantable cardioverter-defibrillator therapy and its complications in idiopathic ventricular fibrillation patients.
    Blom LJ; Visser M; Christiaans I; Scholten MF; Bootsma M; van den Berg MP; Yap SC; van der Heijden JF; Doevendans PA; Loh P; Postema PG; Barge-Schaapsveld DQ; Hofman N; Volders PGA; Wilde AA; Hassink RJ
    Europace; 2019 Oct; 21(10):1519-1526. PubMed ID: 31114860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcutaneous Implantable Cardioverter-Defibrillator Lead Extraction: First Multicenter French Experience.
    Behar N; Galand V; Martins RP; Jacon P; Badenco N; Blangy H; Alonso C; Guy-Moyat B; El Bouazzaoui R; Lebon A; Giraudeau C; Marquie C; Leclercq C
    JACC Clin Electrophysiol; 2020 Jul; 6(7):863-870. PubMed ID: 32703570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inappropriate discharges of intravenous implantable cardioverter defibrillators owing to lead failure.
    Washizuka T; Chinushi M; Kazama R; Hirono T; Watanabe H; Komura S; Sugiura H; Tanabe Y; Furushima H; Fujita S; Okura Y; Aizawa Y
    Int Heart J; 2005 Sep; 46(5):909-13. PubMed ID: 16272782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case.
    Nakao Y; Suenari K; Yamashiro K; Nakagawa H; Shiode N
    BMC Cardiovasc Disord; 2020 Mar; 20(1):134. PubMed ID: 32169057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unique technique to relieve left ventricular assist device electromagnetic interference with an implantable cardioverter defibrillator.
    Jin C; Hsu J; Frenkel D; Jacobson JT; Iwai S; Ferrick A
    J Cardiovasc Electrophysiol; 2021 Feb; 32(2):551-553. PubMed ID: 33345375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure.
    Gunderson BD; Gillberg JM; Wood MA; Vijayaraman P; Shepard RK; Ellenbogen KA
    Heart Rhythm; 2006 Feb; 3(2):155-62. PubMed ID: 16443529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections.
    Castro L; Pecha S; Linder M; Vogler J; Gosau N; Meyer C; Willems S; Reichenspurner H; Hakmi S
    J Cardiothorac Surg; 2017 Nov; 12(1):99. PubMed ID: 29178898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double Twist.
    Lee WC; Chen YL
    Int Heart J; 2021 Sep; 62(5):1156-1159. PubMed ID: 34544971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.